Dynlt1 — Dynein Light Chain Tctex Type 1 plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Dynlt1 — Dynein Light Chain Tctex Type 1 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| Dynein Light Chain Tctex-Type 1 | |
|---|---|
| Gene Symbol | DYNLT1 |
| Full Name | Dynein Light Chain Tctex-Type 1 |
| Chromosome | 6q21 |
| NCBI Gene ID | 6993 |
| OMIM | 162376 |
| Ensembl ID | ENSG00000126653 |
| UniProt ID | P63172 |
| Associated Diseases | Huntington's Disease, Alzheimer's Disease, Retinitis Pigmentosa |
DYNLT1 encodes the Tctex-1 subunit of the cytoplasmic dynein complex, a motor protein that transports cargo along microtubules toward the minus end (retrograde transport). As part of the dynein light chain family, DYNLT1 forms a homodimer and associates with the dynein heavy chain through its intermediate chain. DYNLT1 is involved in retrograde axonal transport of vesicles, organelles, and signaling complexes from nerve terminals to cell bodies. In neurons, dynein-mediated transport is essential for synaptic function, neurotrophin signaling, and clearance of aggregated proteins. DYNLT1 has been implicated in Huntington's disease through altered transport of mutant huntingtin aggregates and in Alzheimer's disease through effects on amyloid-beta transport.
DYNLT1 is expressed in:
High expression in neurons, consistent with its critical role in axonal transport.
| Disease | Role | Mechanism |
|---|---|---|
| Alzheimer's Disease | Risk/Progression | Various mechanisms depending on gene function |
| Parkinson's Disease | Risk/Progression | Various mechanisms depending on gene function |
| Amyotrophic Lateral Sclerosis | Risk/Progression | Various mechanisms depending on gene function |
Targeting DYNLT1 has therapeutic potential in neurodegenerative diseases through:
Dynlt1 — Dynein Light Chain Tctex Type 1 plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Dynlt1 — Dynein Light Chain Tctex Type 1 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.